1. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis;Andres;Neurology,1988
2. Brooks BR, Sufit RL, DePaul R, Tan YD, Sanjak M, Robbins JA. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. In: Rowland LP, editor. Advances in neurology, vol. 56. New York: Raven Press, 1991:521–546.
3. Munsat TL, Hollander D, Andres P, Finison L, Clinical trials in ALS: measurement and natural history. In: Rowland LP, editor. Advances in neurology, vol. 56. New York: Raven Press, 1991:515–519.
4. Smith RA, Melmed S, Sherman B, Frane J, Munsat TL, Festoff BW. Recombinant growth hormone treatment of amyotrophic lateral sclerosis. Muscle Nerve; June, 1993;16(6):624–633.
5. Armon C. In: Gorelick PB, Alter M, editors. Handbook of neuroepidemiology. New York: Marcel Dekker, 1994:407–56.